Efficacy of end-effector Robot-Assisted Gait Training in subacute stroke patients: Clinical and gait outcomes from a pilot bi-centre study.


Journal

NeuroRehabilitation
ISSN: 1878-6448
Titre abrégé: NeuroRehabilitation
Pays: Netherlands
ID NLM: 9113791

Informations de publication

Date de publication:
2019
Historique:
pubmed: 10 9 2019
medline: 23 1 2020
entrez: 10 9 2019
Statut: ppublish

Résumé

End-effector robots allow intensive gait training in stroke subjects and promote a successful rehabilitation. A comparison between conventional and end-effector Robot-Assisted Gait Training (RAGT) in subacute stroke patients is needed. To investigate the efficacy of end-effector RAGT in subacute stroke patients. Twenty-six subacute stroke patients were divided into two group: 14 patients performed RAGT (RG); 12 patients performed conventional gait training (CG). Clinical assessment and gait analysis were performed at the beginning (T0) and at the end (T1) of the rehabilitation. The RG revealed a significant improvement in body function, activities, participation scales, and in the distance measured with the 6 MWT. The affected lower limb's spasticity significantly decreased at T1. In gait analysis, RG showed significantly increases in many parameters. The CG significantly improved clinical assessments but showed no significant changes in gait parameters. Statistically significant differences between RG and CG were found in MRC-HE, TCT, 10 MWT, 6 MWT, and TUG. No significant difference between groups was registered in gait kinematics. Both rehabilitation treatments produce promising effects in subacute stroke patients. RAGT device offers a more intensive, controlled, and physiological gait training and significantly improved deambulation.

Sections du résumé

BACKGROUND BACKGROUND
End-effector robots allow intensive gait training in stroke subjects and promote a successful rehabilitation. A comparison between conventional and end-effector Robot-Assisted Gait Training (RAGT) in subacute stroke patients is needed.
OBJECTIVE OBJECTIVE
To investigate the efficacy of end-effector RAGT in subacute stroke patients.
METHODS METHODS
Twenty-six subacute stroke patients were divided into two group: 14 patients performed RAGT (RG); 12 patients performed conventional gait training (CG). Clinical assessment and gait analysis were performed at the beginning (T0) and at the end (T1) of the rehabilitation.
RESULTS RESULTS
The RG revealed a significant improvement in body function, activities, participation scales, and in the distance measured with the 6 MWT. The affected lower limb's spasticity significantly decreased at T1. In gait analysis, RG showed significantly increases in many parameters. The CG significantly improved clinical assessments but showed no significant changes in gait parameters. Statistically significant differences between RG and CG were found in MRC-HE, TCT, 10 MWT, 6 MWT, and TUG. No significant difference between groups was registered in gait kinematics.
CONCLUSIONS CONCLUSIONS
Both rehabilitation treatments produce promising effects in subacute stroke patients. RAGT device offers a more intensive, controlled, and physiological gait training and significantly improved deambulation.

Identifiants

pubmed: 31498139
pii: NRE192778
doi: 10.3233/NRE-192778
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

201-212

Auteurs

Irene Aprile (I)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Chiara Iacovelli (C)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Michela Goffredo (M)

Department of Neurorehabilitation, IRCCS San Raffaele Pisana, Rome, Italy.

Arianna Cruciani (A)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Manuela Galli (M)

Department of Neurorehabilitation, IRCCS San Raffaele Pisana, Rome, Italy.
Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.

Chiara Simbolotti (C)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Cristiano Pecchioli (C)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Luca Padua (L)

Department of Geriatrics, Neuroscience and Orthopedics, Universitá Cattolica del Sacro Cuore, Rome, Italy.
Unitá operativa di Neuroriabilitazione ad Alta Intensitá, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Daniele Galafate (D)

Department of Neurorehabilitation, IRCCS San Raffaele Pisana, Rome, Italy.

Sanaz Pournajaf (S)

Department of Neurorehabilitation, IRCCS San Raffaele Pisana, Rome, Italy.

Marco Franceschini (M)

Department of Neurorehabilitation, IRCCS San Raffaele Pisana, Rome, Italy.
San Raffaele University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH